semaglutide order Weight-loss GLP-1 pill approved for first time by FDA, Novo Nordisk says ⚠️ Important Patient Update: Semaglutide

Certificates of Analysis Locate available product and batch reports

Your healthcare provider can help manage the symptoms and may adjust the dose or schedule of your medication if needed

In a direct head-to-head trial published in 2024 (SURMOUNT-5), Zepbound produced 47% greater relative weight loss than Wegovy (20.2% vs 13.7%), the first and only superiority result ever demonstrated between two FDA-approved weight loss medications

Journal: S.S. Srinivasan et al. A vibrating ingestible bioelectronic stimulator modulates gastric stretch receptors for illusory satiety. Science Advances. Vol. 9, December 22, 2023